NCT06087588View on ClinicalTrials.gov

Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

January 10, 2025

Study Completion Date

January 14, 2025

Conditions
OsteoarthritisOsteoarthritis, Hip
Interventions
DRUG

0.9%sodium chloride

PENG sham block with 20ml 0,9% normal saline

DRUG

95% ethanol

PENG neurolysis with 2.5ml of 95% ethanol

Trial Locations (1)

61-701

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06087588 - Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis | Biotech Hunter | Biotech Hunter